GlassScriptPhysician profile
Todd M Bayer
NPI 1356343008
$3,392.19
in general payments reported to CMS, 2019-2025
30 companies · $759 in 2025
The $759 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $326 · 2021: $386 · 2022: $651 · 2023: $396 · 2024: $302 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $763.16 | 2019-2022 | |
| Cook Medical LLC | $329.86 | 2019-2025 | Zenith Spiral-Z, Torcon Nb, Zilver Ptx |
| W. L. Gore & Associates, INC. | $317.18 | 2020-2025 | Gore Excluder Aaa Endoprosthesis |
| Medtronic, INC. | $223.76 | 2023-2025 | Endurant Iis, Attain Command + Surevalve |
| Stryker Corporation | $209.64 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Philips North America LLC | $191.13 | 2024-2025 | IV Other, Intrasight Mobile, (Bh4) Igt Devices Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.74 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $181.48 | 2019-2025 | Ekosonic, Watchman Access System |
| Atricure, INC. | $172.90 | 2019-2021 | |
| Lemaitre Vascular, INC. | $166.97 | 2019-2025 | Restoreflow |
| Inari Medical, INC. | $110.61 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $77.78 | 2022-2023 | Angiovac, Auryon Laser System 100-120 Vac |
| Cardiva Medical, INC. | $56.40 | 2022-2024 | Cardiva Vascade 6/7f Vcs |
| Bard Peripheral Vascular, INC. | $50.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $42.73 | 2020-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $34.01 | 2025 | Symphony Catheter |
| Abbott Laboratories | $33.13 | 2024 | Cardiomems, Esprit |
| Sanofi-Aventis U.S. LLC | $32.68 | 2024 | |
| Pfizer INC. | $27.68 | 2019-2023 | |
| Cardiovascular Systems INC. | $24.59 | 2022 | |
| Heartflow, INC. | $23.26 | 2021 | |
| Getinge USA Sales, LLC | $22.81 | 2020 | |
| Solventum Corporation | $21.00 | 2025 | Prevena, Activ.A.C., V.A.C.Instill |
| Argon Medical Devices, INC. | $19.30 | 2024 | Clot Management |
| Bolton Medical INC | $19.27 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Tactile Systems Technology INC | $12.67 | 2019 | |
| Terumo Medical Corporation | $11.72 | 2019 | |
| Artivion, INC. | $11.32 | 2019 | |
| Thrombolex, INC. | $9.77 | 2023 | |
| Surmodics, INC. | $6.64 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Bayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.